Home > Press > RedChip Visibility Issues Research Update On BioForce Nanosciences Holdings, Inc.
Abstract:
RedChip Visibility, a division of RedChip Companies, Inc., announced that it has issued a second quarter research update on BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH).
Tony Telan, RedChip Research Analyst, wrote in the report:
"BioForce Nanosciences, Inc.(OTCBB:BFNH), a developer of nanotechnology instruments, consumables, and applications for the life sciences industry, announced the completion of a financing transaction valued up to $3.45 million. The transaction entailed sales to an institutional investor of Series A 8% Convertible Preferred Stock at $0.50 per share and a series of warrants with exercise prices ranging from $0.50 to $1.25 per share. Notably, the transaction is structured at a fixed price and therefore protects the interests of current shareholders.
"In summary, we continue to believe BFNH offers a compelling investment opportunity for those seeking exposure to micro-cap nanotechnology equities. With a current market cap of less than $16 million, BFHN is undervalued given the expected trajectory of near-term revenue growth and the large ultimate market potential of the Company's product offering. Using sales of AFMs as a proxy for market size and assuming approximately 8,000 AFM sales to date yields a potential market of $1.3 billion (8,000 systems x $160,000 per system) for the NeN system, or $800 million assuming a lower sales target (5,000 systems). Note this analysis conservatively does not include 1) follow on sales of consumables (e.g. the "ink cartridge" and "paper"), 2) potential price increases for high throughput product enhancements or 3) intellectual property related to its ViriChip and Chip-on-a-Tip product development initiatives."
To receive a complimentary copy of the RedChip Visibility research update for BFNH, please visit:
http://www.redchip.com/visibility/about.asp?page=requestbfnh_q2_2007&from=newsbfnh10262007
####
About RedChip Companies, Inc.
RedChip Companies is an international small-cap research and financial public relations firm with offices in Beijing and Orlando and affiliates in New York and San Diego. RedChip delivers measurable results for its clients through its extensive international market expertise as well as its comprehensive platform of products: RedChip Research, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences held throughout the United States, RedChip Radio, and RedChip TV.
To learn more about RedChip's products and services please visit:
http://www.redchip.com/visibility/services.asp
Disclosures
The analysts contributing to this report do not hold any shares of BFNH. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. RedChip certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. Additional information on the securities mentioned in this report is available upon request. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change. BFNH is a client of RedChip Visibility, a division of RedChip Companies. BFNH paid RedChip Visibility $32,400 for the RedChip Visibility Research Program, which includes this report. RedChip Visibility has been contracted by BFNH to increase investor awareness of BFNH to the small-cap equity community. These services may include investor conferences and digital and print distribution of BFNH investor related materials. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that RedChip was hired by the Company and receives a monthly fee of $5,500 and warrants to purchase 80,000 shares of the Company's common stock.
For more information, please click here
Contacts:
BioForce Nanosciences
515-233-8333
RedChip Companies, Inc.
Investor Relations:
1-800-RedChip ext. 127
Copyright © PrimeNewswire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Tools
Ferroelectrically modulate the Fermi level of graphene oxide to enhance SERS response November 3rd, 2023
The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023
Nanobiotechnology
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||